Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

RTX

Raytheon Technologies' Stock Continues Upward Trend

Raytheon Technologies shares rose 1.3% this morning to a price of $140.9. The stock is still trading within range of its average target price of $140.28, and over the last 52 weeks, it has recorded a 31.9% performance. Analysts have given the Large-Cap Aerospace & Defense stock target prices ranging from $114.0 to $160.0 dollars per share, with an average rating of buy.

The stock has a very low short interest at 0.9%, and a short ratio of 2.04. At 0.08%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that a significant number of institutional investors are invested in the stock, with 82.9% of Raytheon Technologies's shares being owned by this investor type.

Institutions Invested in Raytheon Technologies

Date Reported Holder Percentage Shares Value
2025-03-31 Vanguard Group Inc 9% 119,836,487 $16,884,960,286
2025-03-31 State Street Corporation 8% 112,154,824 $15,802,614,017
2025-03-31 Blackrock Inc. 7% 98,251,756 $13,843,671,820
2025-03-31 Capital Research Global Investors 6% 77,811,256 $10,963,605,495
2025-03-31 Capital International Investors 4% 54,370,669 $7,660,826,930
2025-03-31 Dodge & Cox Inc 3% 42,353,562 $5,967,616,627
2025-03-31 Bank of America Corporation 2% 29,183,945 $4,112,017,672
2025-03-31 Geode Capital Management, LLC 2% 28,742,069 $4,049,757,346
2025-03-31 Morgan Stanley 2% 28,747,942 $4,050,584,852
2025-03-31 JPMORGAN CHASE & CO 2% 23,274,461 $3,279,371,412

Besides an analyst consensus of little upside potential, other market factors point to there being mixed market sentiment on Raytheon Technologies.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS